In recent years, the public reported the shortage of rabies vaccine for human use in Lijiang City of Yunnan Province through the mayor’s hotline and telephone calls. Lijiang Health Committee made a public response on October 12. According to the national regulations on vaccine management, municipal disease control departments can not directly participate in the procurement and vaccination of non immunization program vaccines. At present, the rabies vaccine for human use in Lijiang City is purchased by the CDC of each county through the public resource platform of Yunnan Province, and then distributed to the vaccination units. Since September 2019, there has been a nationwide shortage of human rabies vaccine, and it is difficult to meet the demand for human rabies vaccine purchased by CDCs of all counties on the procurement platform. According to Lijiang Health Commission, in recent years, the annual consumption of rabies vaccine in Lijiang is more than 40000. Among them, 44425 pieces were purchased and 42325 pieces arrived in 2018, with the supply rate of 95.27%; in 2019, 47925 pieces were purchased and 27025 pieces arrived, with the supply rate of 56.39%; in 2020, 74050 pieces were purchased and 10550 pieces arrived, with the supply rate of only 14.25%.
in response to the shortage of Purified Hamster Kidney Cell Rabies Vaccine, Lijiang Health Committee has taken measures to deal with the situation. First, report the shortage of Purified Hamster Kidney Cell Rabies Vaccine in the city to the provincial level, and strive for support; two, urge the counties to actively contact the successful companies to improve the delivery rate; three, through the official account of “healthy Lijiang”, the announcement of the shortage of Purified Hamster Kidney Cell Rabies Vaccine in the city is made. We should wake up the general public and improve their self-defense awareness. In May this year, Lijiang Center for Disease Control and Prevention (CDC) issued a notice to strengthen vaccine management and ensure vaccine quality and supply. Since the implementation, the State Food and drug administration, the national health and Health Commission and other departments have issued strict control measures on vaccine manufacturers, requiring enterprises with aging production processes and insufficient production capacity Due to the upgrading and transformation of the industry, the market supply of rabies vaccine for human use in Yunnan Province and even the whole country is insufficient, and the supply of rabies vaccine for human use is in short supply. At that time, Lijiang Center for Disease Control and prevention revealed that the rabies vaccine for human use in Lijiang City was purchased by the CDC of each county from the production enterprises according to law, and the vaccine was delivered to the vaccination clinic in the jurisdiction area by cold chain. Since March 2020, vaccine manufacturers supplying rabies vaccine for human use in Lijiang City have been cut off or unable to supply enough due to insufficient production capacity and low dosage. Although the municipal and county centers for Disease Control and prevention actively communicated and coordinated with the suppliers and reported to the provincial centers for Disease Control and prevention, no human rabies vaccine was purchased. In view of the insufficient supply of rabies vaccine for human use in Lijiang City, it is suggested that the majority of urban and rural residents in Lijiang should properly manage and keep away from animals such as dogs and cats, so as to avoid the occurrence of injuries caused by the above animals. < p > < p > in June this year, in response to the shortage or even shortage of rabies vaccine for human use in some areas, the National Health Commission responded that since 2018, due to the shutdown of some related enterprises, the production of rabies vaccine has decreased, and the original stock in the market has been greatly consumed, and the supply of the vaccine is in a tight balance. 08/16/2020